Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.20 is 53% below its 5-year average of 2.58, near the low end of its 5-year range (0.63–5.89).
As of the fiscal period ended Tuesday, June 30, 2026. 17.91% above its 12-month average of 1.02.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.20.
CURRENT RATIO
1.20
CURRENT RATIO AVG TTM
1.02
CURRENT RATIO AVG 3Y
1.70
CURRENT RATIO AVG 5Y
2.58
CURRENT RATIO AVG 10Y
2.40
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.91%
CURRENT VS 3Y AVG
-29.49%
CURRENT VS 5Y AVG
-53.40%
CURRENT VS 10Y AVG
-50.06%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-67.99%
vs the sector median at left
Market Cap
$19.41M
Current Ratio
1.25
TTM Avg
1.72
3Y Avg
2.15
5Y Avg
2.15
Market Cap
$18.70M
Current Ratio
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$17.99M
Current Ratio
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | $19.96M | 1.20 | 1.02 | 1.70 | 2.58 |
| NextCure, Inc. (NXTC)vs › | $20.39M | 3.47 | 5.82 | 11.50 | 18.06 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.41M | 1.25 | 1.72 | 2.15 | 2.15 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.70M | 27.85 | 15.71 | 9.25 | 10.43 |
| P3 Health Partners Inc. (PIII)vs › | $18.61M | 0.46 | 0.30 | 0.39 | 0.60 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.79M | 1.13 | 1.19 | 1.11 | 1.05 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.20 | 0.34 | 6.34 | 6.11 |
| Cosmos Health Inc. (COSM)vs › | $17.68M | 1.05 | 0.99 | 1.52 | 1.43 |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 3.25 | 7.36 | 6.38 | 5.95 |
| LeonaBio, Inc. (LONA)vs › | $22.28M | 7.01 | 3.03 | 5.28 | 15.47 |
Current Ratio
1.20
Quick Ratio
1.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.20 |
| 2026-03-31 | 0.63 |
| 2025-12-31 | 1.07 |
| 2025-09-30 | 1.41 |
| 2025-06-30 | 0.78 |
| 2025-03-31 | 0.96 |
| 2024-12-31 | 1.80 |
| 2024-09-30 | 3.76 |
| 2024-06-30 | 1.99 |
| 2024-03-31 | 2.34 |
| 2023-12-31 | 2.43 |
| 2023-09-30 | 2.20 |
| 2023-06-30 | 1.56 |
| 2023-03-31 | 1.25 |
| 2022-12-31 | 2.28 |
| 2022-09-30 | 3.41 |
| 2022-06-30 | 3.98 |
| 2022-03-31 | 4.47 |
| 2021-12-31 | 5.28 |
| 2021-09-30 | 5.89 |
| 2021-06-30 | 5.40 |
| 2021-03-31 | 7.73 |
| 2020-12-31 | 4.82 |
| 2020-09-30 | 2.62 |
| 2020-06-30 | 4.83 |
| 2020-03-31 | 3.63 |
| 2019-12-31 | 1.25 |
| 2019-09-30 | 1.81 |
| 2019-06-30 | 3.20 |
| 2019-03-31 | 15.17 |
| 2018-12-31 | 12.94 |
| 2018-09-30 | 121.21 |
| 2018-06-30 | 105.77 |
| 2018-03-31 | 1.97 |
| 2017-11-30 | 0.11 |
| 2017-08-31 | 0.16 |
| 2017-05-31 | 0.19 |
| 2017-03-31 | 0.00 |
| 2016-11-30 | 0.00 |
| 2016-08-31 | 0.12 |
| 2016-05-31 | 0.00 |
